atenolol has been researched along with Eye Abnormalities in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Eye Abnormalities: Congenital absence of or defects in structures of the eye; may also be hereditary.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderón-Castrat, X | 1 |
| Castro, R | 1 |
| Casamayor, E | 1 |
| Zavala, K | 1 |
1 other study available for atenolol and Eye Abnormalities
| Article | Year |
|---|---|
Phaces syndrome successfully treated with oral atenolol.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aortic Coarctation; Atenolol; Eye Abno | 2020 |